These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27676693)

  • 1. Cancer stem cells: A product of clonal evolution?
    van Niekerk G; Davids LM; Hattingh SM; Engelbrecht AM
    Int J Cancer; 2017 Mar; 140(5):993-999. PubMed ID: 27676693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast-cancer stem cells-beyond semantics.
    Badve S; Nakshatri H
    Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells: in the line of fire.
    Alison MR; Lin WR; Lim SM; Nicholson LJ
    Cancer Treat Rev; 2012 Oct; 38(6):589-98. PubMed ID: 22469558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.
    Kilmister EJ; Tan ST
    J Histochem Cytochem; 2021 Dec; 69(12):835-847. PubMed ID: 34165363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Die hard: are cancer stem cells the Bruce Willises of tumor biology?
    Fábián A; Barok M; Vereb G; Szöllosi J
    Cytometry A; 2009 Jan; 75(1):67-74. PubMed ID: 19051297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
    Prick J; de Haan G; Green AR; Kent DG
    Exp Hematol; 2014 Oct; 42(10):841-51. PubMed ID: 25201757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer defeating? Challenge accepted!
    Di Franco S; Todaro M; Dieli F; Stassi G
    Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on targeting effect and regulating mechanisms of the stemness of cancer stem cells].
    Ma HY; He M; Wei MJ
    Yao Xue Xue Bao; 2016 Feb; 51(2):189-96. PubMed ID: 29856198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
    Borst P
    Open Biol; 2012 May; 2(5):120066. PubMed ID: 22724067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
    Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
    Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of cancer stem cells in the treatment of cancer.
    Pan CX; Zhu W; Cheng L
    Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells--the current status of an old concept: literature review and clinical approaches.
    Fulawka L; Donizy P; Halon A
    Biol Res; 2014 Dec; 47(1):66. PubMed ID: 25723910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells in breast cancer.
    Dittmer J; Rody A
    Histol Histopathol; 2013 Jul; 28(7):827-38. PubMed ID: 23468411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
    De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
    Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
    Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
    Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.